43. Microscopic polyangiitis Clinical trials / Disease details
Clinical trials : 88 / Drugs : 81 - (DrugBank : 21) / Drug target genes : 15 - Drug target pathways : 90
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | JPRN-JapicCTI-132394 | 07/3/2014 | 25/12/2013 | Phase 3 study of GGS in patients with microscopic polyangiitis (MPA) | Randomized, placebo-controlled, double-blind, parallel-group clinical study of GGS in patients with microscopic polyangiitis (MPA) (Phase 3 study) | Microscopic polyangiitis (MPA) | Intervention name : Freeze-Dried Sulfonated Human Normal Immunoglobulin (GGS) INN of the intervention : - Dosage And administration of the intervention : Intravenous drip infusion Control intervention name : Placebo (physiological saline) INN of the control intervention : - Dosage And administration of the control intervention : Intravenous drip infusion | TEIJIN PHARMA LIMITED | NULL | complete | 20 | BOTH | 36 | Phase 3 | Japan |